ABIS-45RC

N/A

Report date: 2023/11/07 14:57:01

Base Information

Drug NameABIS-45RC
Drug Alias NameABIS-45RC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-CD45
TargetsLeukocyte common antigen
Therapy Area/IndicationsGraft vs Host DiseaseMuscular Dystrophy, DuchenneArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbolerIS Pharma SAS
China Registration ClassN/A

Develop Information

Active CompaniesAbolerIS Pharma SAS
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseMuscular Dystrophy, DuchenneArthritis, Rheumatoid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A